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OBJECTIVE: Ophthalmologic examination for retinopathy of prematurity is a painful procedure.
Pharmacological and non-pharmacological interventions have been proposed to reduce pain during eye
examinations. This study aims to evaluate the analgesic effect of 25% glucose using a validated pain scale
during the first eye examination for retinopathy of prematurity in preterm infants with birth weight #1,500 g
and/or gestational age #32 weeks.
METHODS: A masked, randomized clinical trial for one dose of 1 ml of oral 25% glucose solution 2 minutes
before the first ophthalmologic examination for retinopathy of prematurity was conducted between March
2008 and April 2010. The results were compared to those of a control group that did not receive oral glucose
solution. Pain was evaluated using a Neonatal Infant Pain Scale immediately before and immediately after the
ophthalmologic examination in both groups. Clinicaltrials.gov: NCT00648687
RESULTS: One hundred and twenty-four patients who were examined for the first time for retinopathy of
prematurity were included. Seventy were included in the intervention group and 54 in the control group. The
number of patients with pain immediately before the procedure was similar in both groups. The number of
patients with pain after ophthalmologic examination was 15.7% in the intervention group and 68.5% in the
control group (p,0.001).
CONCLUSIONS: One ml of oral 25% glucose solution given 2 minutes before an ophthalmologic examination
for retinopathy of prematurity was an effective measure for pain relief.
KEYWORDS: Premature; Retinopathy of Prematurity; Pain; Pain Measurement; Stress; Neonatal Infant Pain
Scale (NIPS).
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& INTRODUCTION
Retinopathy of prematurity (ROP) is a leading cause of
childhood preventable blindness in middle-income coun-
tries (1). Ophthalmologic examination is the best way to
detect ROP but is a painful procedure and causes stress and
physical debilitation, especially because of the use of the
eyelid speculum or scleral indentation (2-6). The use of local
anesthetic eye drops before an eye examination is a partially
effective therapeutic procedure (7).
Recent studies have proposed the use of pharmacological
and non-pharmacological interventions, such as sweet solu-
tions (oral sucrose or glucose solutions) with or without non-
nutritive suck, swaddling and a pacifier to minimize pain
during eye examinations for ROP. The influence of nesting
without topical anesthesia to minimize pain during the
screening for ROP was previously evaluated with controver-
sial results. Fewer body movements were observed in the
nested group, including movements of the distal limb,
proximal limb and trunk, relative to the non-nested group
prior to, during and after the ROP examination (8). The
authors suggested that the benefits of some of the non-
pharmacological pain measures were dependent on the age
of the neonate at the time the examination was performed
(8,9). Although the efficacy of these approaches is clearly
evident, they cannot provide analgesia for moderate or severe
pain in the neonate (8-12). Pharmacological interventions
used to treat neonatal pain include opiates, benzodiazepines,
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barbiturates, ketamine, propofol, acetaminophen and local
and topical anesthetics. However, the indications, advantages
and disadvantages of commonly used analgesic drugs and
non-pharmacolgical interventions in the neonatal period are
controversial and require further study (8,11).
The effect of oral glucose for analgesia in newborns is
known. Glucose solutions are routinely used for intrave-
nous infusions because they are readily available in
neonatal intensive care units (NICU) and they are the
preferred sweet solution used in our institution (13,14).
The objective of this study was to analyze the analgesic
effect of 25% glucose to reduce the frequency of pain during
the first eye examination for ROP in preterm infants with
birth weight (BW) #1,500 g and/or gestational age (GA) at
birth #32 weeks. Pain was evaluated by using a validated
Neonatal Infant Pain Scale (NIPS).
& METHODS
Study design
A masked randomized clinical trial with or without the
oral administration of 1 ml of 25% glucose solution 2
minutes before an ophthalmologic examination for ROP in
preterm infants with BW #1,500 g and/or GA#32 weeks at
birth was conducted between March 2008 and April 2010.
Patients were randomly assigned to one of the two groups.
The randomization was computerized. We included
patients that received oral glucose solution in the interven-
tion group (Group 1) and patients that did not receive oral
glucose in the control group (Group 2). A placebo was not
used in the control group so that it would be as similar as
possible to the ophthalmological examination routinely
performed in our NICU. The study flow diagram followed
the CONSORT statement (Figure 1).
Population
Screening to detect ROP is performed weekly in 93 to 95%
of all admitted very-low-birth-weight (VLBW) preterm
infants. We included all patients with BW #1,500 g and/
or GA #32 weeks who were examined for the first time for
ROP in this clinical trial. There were no exclusion criteria.
Interventions
The main intervention was the administration of 1 ml of
oral 25% glucose solution in a single dose by syringe
without sucking 2 minutes before the eye examination. The
ophthalmologic examination was conducted according to
the Brazilian guidelines for ROP screening (15) and was
always performed by the same author (JBFF), who was
blinded to the intervention and blinded to the NIPS scores.
The eyes were evaluated by binocular indirect ophthalmo-
scopy using a 28 D Nikon lens (NikonH, Melville, NY, USA)
and a lid speculum for newborns (Alfonso Eye Speculum,
StorzH, Bausch & Lomb Inc., San Dimas, CA, USA) after
dilation of the pupils with eye drops containing tropicamide
0.5% and phenylephrine 2.5%. Scleral indentation was used
to achieve a better examination of peripheral zone III. Local
anesthetic eye drops (proxymetacaine 0.5%) were used in all
patients prior to the introduction of the eyelid speculum. All
infants were first examined between four and six weeks of
life.
For the study, we considered only the first ophthalmolo-
gic examination to avoid the influence of "pain memory".
The same type of speculum and indentor were used to
maintain consistency throughout the study period. The
mean examination time for each patient was approximately
2 minutes per eye.
Pain response evaluation and variables
We used the NIPS scale to evaluate the presence of pain
(16). The NIPS scale considers facial expression, crying,
breathing pattern, arms, legs and state of arousal as
variables. Scores equal or greater than 4 were considered
to be positive for pain. The NIPS score evaluation was
performed 2 minutes before and 2 minutes after the
ophthalmologic examination by two different evaluators.
The NIPS evaluators were independent and unaware of
each other’s results. The NIPS evaluators were also blinded
to the intervention. We considered the mean score of both
examiners before and after examination. The examiners
were NICU nurses who had extensive experience with the
NIPS score in our NICU. We used the Kappa coefficient to
analyze the concordance between both evaluators regarding
the NIPS scores (NIPS ,4 and NIPS .4) before and after the
eye examination.
Data on BW, GA, postconceptional age (PCA), weight of
the preterm and the NIPS score at baseline was evaluated in
all patients included in this study (Group 1 Intervention and
Group 2 Control). The main outcome was the variation of
the NIPS scores before and after the ophthalmological
examination to detect ROP.
Figure 1 - Flow diagram for the included patients in each step of
the study.
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A sample size of 50 patients in each group was calculated
after a pilot trial with 20 patients in each group to obtain a
90% study power and a 5% significance level. The initial
sample size was calculated to detect a mean difference of 0.6
in the NIPS score from before and after the eye examination
in both groups.
The NIPS score was evaluated as a continuous variable by
repeated-measures ANOVA and as a categorical variable
(NIPS$4) by Chi-square analysis. Repeated-measures
ANOVA was used to evaluate the difference between the
two groups regarding time (before and after the eye
examination). Analyses for the evolution of the groups before
and after the eye examination (P interaction), time (P time),
and comparison between groups (P group) are presented.
Differences were considered significant if p,0.05.
The statistical analysis was performed using Statistical
Package for Social Sciences software (SPSS 15.0 for
Windows, SPSS Inc., Chicago, IL, USA).
Ethics
The parents or legal representatives signed a consent form
for all newborns included in the study. The study protocol
was approved by the Ethics Committee of the HCPA
(number 07-437) and it was registered with the Clinical
Trials of the US National Institutes of Health (number
NCT00648687).
The authors certify that the protocol for the research
project conformed to the provisions of the Declaration of
Helsinki of 1995 (as revised in Edinburgh 2000) and declare
no financial support or relationships that may pose a
conflict of interest.
& RESULTS
In total, 124 VLBW preterm infants were included in the
study: 70 newborns were included in the intervention group
and 54 in the control group. A CONSORT-based diagram
showing patient flow through each step of the trial is shown
in Figure 1.
The mean BW and GA of the 124 included newborn
infants were 1,261.3¡273.1 g and 30.2¡2.0 weeks, respec-
tively. Thirty patients (24.2%) had a BW #1,000 g and 48
patients (38.7%) were small for GA (,10th percentile). The
PCA at the first ophthalmological examination in the entire
cohort ranged from 31 to 37 weeks (mean 34.6¡1.2 weeks).
The data regarding BW, GA, PCA and weight of the preterm
infant on the examination day in each group of the study are
displayed in Table 1. On the scheduled day of the
ophthalmological examination, all of the patients were
evaluated by the neonatologist-in-charge and were consid-
ered to be sufficiently healthy to undergo screening for
ROP. None of the patients were on mechanical ventilation
and all were clinically stable. After the eye examination,
none of the patients required any clinical or pharmacologi-
cal intervention to minimize pain.
According to the data displayed in Table 1, both groups
were similar at baseline in terms of BW, GA, PCA and
weight on the day of the eye examination.
Prior to the examination, the mean NIPS score was
0.8¡0.8 and 1.2¡1.2 (p= 0.100) in the intervention and
control groups, respectively. After the examination, the
mean NIPS score increased to 2.6¡1.1 in the intervention
group, whereas the score increased to 4.5¡1.3 in the control
group (p,0.001). The inter-examiner reliability of the NIPS
scale (kappa) in our study was 0.70. With the inclusion of 70
patients in the intervention group and 54 patients in the
control group, our study achieved a power of 100% to detect
a difference of 1.9 in the mean NIPS score between the
groups (4.5-2.6) after examination for ROP with a standard
deviation of 1.1 (intervention group) and 1.3 (control group).
When the NIPS score was categorized for pain (NIPS$4),
only one patient (1.4%) in the intervention group and two
patients (3.7%) in the control group had pain prior to the eye
examination (p= 0.580). After the eye examination, we
observed 11 patients with pain (NIPS$4) in the intervention
group (15.7%) and 37 patients with pain (68.5%) in the
control group (p,0.001). The NIPS evaluations before and
after the ophthalmologic examination in both groups are
shown in Table 2 and Figure 2.
Table 1 - Demographic data of eligible VLBW infants.
Group 1 Intervention n=70 patients Group 2 Control n= 54 patients p-value
BW g* 1,287.80¡255.1 1,227.00¡293.6 0.229
GA weeks * 30.5¡1.9 29.9¡2.0 0.073
Weight at examination day * 1,904.40¡330.2 1,801.00¡363.8 0.101
PCA at examination day * 34.9¡1.1 34.3¡1.2 0.754
VLBW: very low birth weight; *: Data in mean ¡ standard deviation; BW: birth weight; GA: gestational age, PCA: postconceptional age.
Table 2 - NIPS scores before and after the eye examination for ROP.









NIPS$4 n (%) 1 (1.4%) 2 (3.7%) 0.580 11 (15.7%) 37 (68.5%) ,0.001
NIPS mean¡SD 0.8¡0.8 1.2¡1.2 0.100 2.6¡1.1 4.5¡1.3 ,0.001
NIPS: Neonatal Infant Pain Scale; SD: standard deviation.Repeated-measures ANOVA: P time,0.001; P interaction,0.001; P group,0.001.
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Repeated-measures ANOVA revealed different variations
in the intervention group relative to the control group (P
interaction ,0.001, Table 2).
& DISCUSSION
Our data showed that 1 ml of oral 25% glucose solution
given 2 minutes before an ophthalmologic exam for ROP
was efficient for pain relief. After the exam, patients in the
control group had a mean NIPS score that was significantly
higher than the score for patients in the intervention group.
Furthermore, the control group had significantly more
patients with pain (NIPS$4) than the intervention group.
The ophthalmologic examination for ROP has been
demonstrated to be a painful procedure that causes stress
as well as physical and psychological distress in preterm
infants (2,17,18). Anesthetic eye drops partially minimize
the pain caused by eyelid speculum insertion, scleral
indentation and the bright light of the binocular indirect
ophthalmoscope during the eye exam for ROP (7,19,20).
However, even with the use of anesthetic eye drops, pain is
still present during the eye exam. In the present study, both
groups were treated with anesthetic eye drops before the
ophthalmologic examination and significantly more patients
in the control group had a high NIPS score immediately
after the examination.
Non-pharmacological measures have been proposed for
neonatal pain relief, such as being held by nurse, use of
maternal milk, nesting, non-nutritive sucking and the
administration of oral glucose or sucrose solutions (8,11).
Samra et al. (9) and Sum et al. (11) reported studies on the
administration of oral sucrose for pain relief during an ROP
screening examination. In most other studies, the efficacy of
24% sucrose solution was evaluated; in one study, 33%
sucrose solution was tested. The volume administered, time
of administration and number of doses differed among the
studies. Mitchell et al. (8) administered three doses of 0.1 ml
of 24% sucrose solution before an eye examination in 15
patients. Gal et al. (21) used 2 ml of 24% sucrose solution in
a cross-over placebo-controlled study with 22 patients.
Grabska et al. (22) conducted a placebo-controlled study
with 16 patients in the intervention group who received 24%
sucrose solution and adjusted the sucrose dose from 0.12 to
0.48 ml according to the patient’s weight. Boyle et al. (10)
used 1 ml of 33% sucrose solution in 10 patients. These
studies show that sucrose administration before ophthal-
mologic examination reduces pain, but the results were
often confounded by the non-nutritive sucking effect.
However, some studies did not show a significant effect of
pain relief for sucrose or oral glucose (23,24).
Oral glucose to relieve pain and minimize distress among
newborns is commonly used in neonatology and it is the
preferred solution used at our institution. Orally adminis-
tered glucose has a clearly demonstrated pain-reducing
effect in newborns, but the mechanisms underlying this
effect remain unknown (25) and controversial. Slater et al.
(26) stated that oral sucrose does not significantly affect
activity in the neonatal brain or spinal cord nociceptive
circuits. Therefore, it may not be an effective analgesic drug.
The ability of sucrose to reduce clinical observational pain
scores after noxious events in newborn infants should not be
interpreted as pain relief. Wilkinson et al. (27) thus
suggested that sucrose or sugar may be better understood
not as an analgesic that is removing or relieving pain but
rather as a compensating pleasure for the infant.
Olsson and Eriksson studied the pain relief effect of 1 ml
of 30% glucose solution given 1 minute before an eye
examination in 14 infants with gestational age less than 32
weeks and/or birth weight less than 1,500 grams relative to
the effect in 15 control infants that received sterile water.
They included patients who were previously examined and
showed that glucose solution did not alleviate pain
associated with the eye examination (23). We included 70
preterm infants that received 25% glucose solution 2
minutes before their first eye examination and compared
them to 54 control infants. The extra minute before the eye
examination and the exclusion of possible pain memory
from a previous ophthalmologic examination differentiate
our study from the previous study, and these differences
may explain the difference in findings.
We chose to use the NIPS scale, which is appropriate for
term and preterm infants. At the first ophthalmologic
examination, the mean corrected gestational age was higher
than 35 weeks and all of the patients were six weeks old.
These characteristics of the included patients allowed us to
use the NIPS scale for pain evaluation. The NIPS scale is
currently used in most NICUs in Brazil (28-30).
The inter-examiner reliability of the NIPS scale (kappa
coefficient) in our study was 0.70. An inter-examiner
reliability of 0.80 or higher would provide better final
results in our study. Nevertheless, the NIPS evaluators in
our NICU were well-trained nurses with extensive experi-
ence in the use of the NIPS score, which is routinely used in
our hospital.
Some identified limitations of our study were: a) we could
not control for possible previous pain memory other than
that caused by the ophthalmologic examination of each
infant; b) because the NIPS score evaluation was performed
Figure 2 - NIPS score variation before and after the eye
examination.
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2 minutes after the ophthalmologic examination, it is
possible that the infants were still recovering from pain,
which could have resulted in under- or overestimation of
the effects of glucose; and c) scales for pain evaluation are
always subjective. These limitations did not affect the
determination that 1 ml of oral 25% glucose alleviates pain
responses to ophthalmologic examination in VLBW preterm
infants.
Small volumes of glucose solution can be administered
with drops and without the need for suction, which is useful
for VLBW premature newborns that are not able to suck and
for infants who are intubated at the time of their first
ophthalmologic examination.
Currently, there are clear guidelines for ROP examination
in many countries, but there are no established protocols for
pharmacological or non-pharmacological pain management
during ROP examinations (9). The findings of our study are
relevant because they show that 1 ml of oral 25% glucose
solution in a single dose administered 2 minutes prior to
eyelid speculum insertion is effective for pain relief
produced by the ROP examination.
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